Diagenics is a biopharmaceutical company.
Diagenics SE is paving the way for scientific ideas to become fully-developed products in the industry. Diagenics wants to take a unique position in the emerging market of biotechnology by not only developing new ideas and selling them, but also by continuing to develop them until they reach full market maturity.
Diagenics SE therefore does not stop merely at the creation of new ideas, but continues to actively market them, thus closing the gap between research and industry. This requires quickly presenting new developments in a marketable way, so that profitable products bring sustained success on the market.